skip to main content

Cancer Genetics

Rogel Cancer Center researchers get $4M to help expand genetic testing efforts statewide

A team of researchers at the University of Michigan Rogel Cancer has been awarded $4 million from the National Cancer Institute as part of its Cancer Moonshot program. The grant will fund efforts to increase rates of genetic testing among cancer patients who have family histories concerning for hereditary cancer syndromes.

What Breast Cancer and Ovarian Cancer Survivors Should Know About New Genetic Testing Recommendations

Breast cancer and/or ovarian cancer survivors should be offered genetic counseling and genetic testing for BRCA1 and BRCA2 genetic mutations, according to new recommendations from the U.S. Preventive Services Task Force.

An Interactive Website Boosts Genetic Testing Knowledge in Breast Cancer Patients

A team at the University of Michigan Rogel Cancer Center recently sought to determine how much newly diagnosed cancer patients understand about the benefits of genetic testing after a diagnosis. Their other objective: to find out whether a decision support tool would help improve that knowledge.

Family genetic counseling can identify children at risk for cancer

As advances in next generation sequencing technology becomes increasingly important in treating adult cancers, the same advances are equally important in managing treatment for pediatric cancer patients. For example, recent work by researchers at the University of Michigan on the Peds-MiOncoSeq study found that identifying mutations present in tumor tissue can lead to changes in treatment recommendations.

Men and Breast Cancer

There is no question that breast cancer disproportionately affects women, but we shouldn't be so quick to dismiss the risk to men. As we continue to learn more about the ways our genes influence our cancer risk, involvement of male relatives in genetic counseling and genetic testing can provide important information for your family's breast cancer risk evaluation.

Pages